Status | Study |
Recruiting |
Study Name: Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis Condition: AL Amyloidosis Date: 2016-12-12 Interventions: Drug: Venetoclax Venetoclax at |
Enrolling by invitation |
Study Name: A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia Condition: Alzheimer's Disease Date: 2016-11-21 Interventions: Drug: Lanabecestat Administered orally Other Names: |
Not yet recruiting |
Study Name: Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients Condition: Amyloidosis; Systemic Date: 2016-11-18 Interventions: Drug: Propylene Glycol-Free Melphalan Hydrochloride Intravenous Propylene Glycol-Free Melphalan Hydrochl |
Recruiting |
Study Name: Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis Condition: Cardiac Amyloidosis Date: 2016-11-08 Interventions: Drug: Thalidomide Drug: Dexamethasone |
Completed |
Study Name: Phase 1 Study of GSK2315698 in Healthy Japanese Subjects Condition: Amyloidosis Date: 2016-11-01 Interventions: Drug: Placebo 0.9% weight by v |
Recruiting |
Study Name: Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis Condition: Dialysis Amyloidosis Date: 2016-10-30 Interventions: Device: Lixelle® treatment The treatment will be performed with the Lixelle® column connected |
Recruiting |
Study Name: Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN) Condition: Alzheimer Disease Amyloid Beta-Peptides Date: 2016-10-24 Interventions: Behavioral: Alzheimer's Disease Risk Disclosure |
Available |
Study Name: Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) Condition: TTR-mediated Amyloidosis Amyloidosis Date: 2016-10-18 Interventions: Drug: patisiran (ALN-TTR02) patisiran (ALN-TTR02) administered by intravenous (IV) infusion |
Recruiting |
Study Name: Sleep Quality and Amyloid-Beta Kinetics Condition: Amyloid-beta Date: 2016-10-17 Interventions: Drug: Suvorexant Participants |
Not yet recruiting |
Study Name: Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging Condition: Mild Cognitive Impairment Biomarker Diagnosis Date: 2016-10-08 Interventions: Drug: Huperzine A The particip |